Developer docs
API playgroundTry for free, no card

Search company profiles

Linear Care Diagnostics

Full company profile

uuid000mgc6

Namestring
Linear Care Diagnostics
Legal namestring
Linear Care Diagnostics
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Linear Care Diagnostics is an independent diagnostic laboratory founded in 2022 and headquartered in Addison, Texas. The company operates a broad testing menu spanning infectious disease (COVID PCR and antigen, UTI, STI, RSV, wound, nail fungal), toxicology and drug screening, specialty oncology surveillance via UroVysion FISH for bladder cancer, and pharmacogenomic (PGx) testing. Underlying methodology combines standard molecular and analytical platforms — PCR, LC-MS/MS, fluorescence in situ hybridization, and PGx — with a proprietary software layer that the company claims delivers 99% accuracy and 24–48 hour result turnaround.

The business model is per-test fee-based, with cash-pay prices ranging from $35 (drug screen without nicotine) to $80 (drug screen with nicotine), and insurance billing for tests such as COVID PCR. Customers are reached through three primary channels: direct-to-consumer online self-scheduling, employer pre-employment and workplace drug screening, and physician referrals, the latter serving chronic pain management and bladder cancer surveillance workflows.

Linear Care Diagnostics reports a headcount in the 11–50 range and claims multiple physical testing locations, though only the Addison, TX site is confirmed. No funding rounds, acquisitions, partnerships, patents, certifications, or major customer accounts are disclosed in the available data. The company's competitive positioning rests on breadth of menu, fast turnaround, and DTC accessibility rather than on disclosed scientific differentiation or regulatory milestones.

Short descriptiontext

Linear Care Diagnostics is an independent diagnostic laboratory in Addison, Texas offering infectious disease, toxicology, specialty oncology, and pharmacogenomic testing to individual patients, employers, and physician referrals via per-test cash-pay and insurance billing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAddison, United States
HQ citystring
Addison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, clinical laboratory services, COVID PCR testing, pharmacogenomics testing, pre-employment drug screening
Industry5 codes
1Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryYes
2Molecular Diagnostics (PCR/qPCR, NGS-based assays)
CodeHLAAALAAPrimaryNo
3Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
CodeHLAAALALPrimaryNo
4Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category)
CodeHLAHAOAHPrimaryNo
5Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Diagnostic Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Diagnostic Testing Services
TypeOne Time License
Description

One-time diagnostic testing services for patients including COVID PCR, antigen testing, UTI testing, STI testing, wound testing, nail fungal testing, RSV testing, pre-employment drug screening, UroVysion FISH, and PGx testing. Revenue is generated through per-test fees with option for insurance billing or cash pay.

linearcaredx.com
2Insurance Billing
TypeTransaction Fee
Description

Accepts most insurance plans with doctor's orders. For uninsured patients, claims can be submitted through the CARES ACT.

linearcaredx.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Pre-employment drug screen without nicotine - $35
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$35 flat rate for pre-employment drug screening without nicotine testing. Cash pay or insurance.

linearcaredx.com
2Pre-employment drug screen with nicotine - $80
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$80 flat rate for pre-employment drug screening including nicotine testing. Cash pay or insurance.

linearcaredx.com
3COVID PCR and Antigen Testing - Insurance accepted
ModelOtherBilling cadencePay-as-you-go
Notes

Accepts all insurance at no cost to the patient. If uninsured, claims submitted through the CARES ACT.

linearcaredx.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Linear Care Diagnostics is a clinical diagnostic laboratory that performs molecular and specialty testing — including COVID PCR, antigen, UTI, STI, wound, nail fungal, RSV, toxicology, UroVysion FISH bladder cancer, and pharmacogenomics (PGx) assays — using PCR, RT-PCR, LC-MS/MS, FISH, and proprietary software to deliver results in 24–48 hours (same-day at Addison, TX) with 99% accuracy. Tests can be ordered through physicians or booked directly by patients via the company website, with insurance or cash-pay billing options.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99% accuracy within 24-48 hours for most test results
+5 more records
Product overview1 text field

Linear Care Diagnostics is a diagnostic laboratory offering a comprehensive suite of medical testing services. The company's portfolio includes COVID PCR Testing and Antigen Testing for respiratory infections, UTI Testing and STI Testing for infectious disease detection, Toxicology Testing and Pre-employment Drug Screening (with nicotine at $80 and without nicotine at $35) for medication monitoring, Wound Testing and Nail Fungal Testing using molecular PCR technology, RSV Testing for respiratory infections, UroVysion FISH Testing for bladder cancer detection, and PGx Testing for pharmacogenomics. The company emphasizes rapid turnaround times (24-48 hours for most tests) and high accuracy (99%+) through proprietary software and advanced analytical instruments.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Full-service clinical lab with significant molecular diagnostics and specialty testing footprint. Comparable broad-incumbent competitor to Linear Care's specialty and routine test menu.

TypeDirect peer
Description

Infectious-disease focused molecular diagnostics lab offering PCR-based testing with rapid turnaround. Directly comparable to Linear Care's infectious-disease menu (UTI, STI, wound, RSV).

TypeDirect peer
Description

Specialty toxicology lab using LC-MS/MS for medication monitoring and substance use detection. Comparable to Linear Care's toxicology and chronic-pain monitoring offerings.

TypeBroad incumbent
Description

One of the two largest US clinical reference laboratories, offering the full range of molecular, toxicology, infectious-disease, and PGx testing. Competes with Linear Care across virtually every line item at national scale.

TypeDirect peer
Description

Specialty clinical lab focused on toxicology, pharmacogenomics, and medication-monitoring testing. Directly comparable to Linear Care's PGx and toxicology services.

TypeEmerging player
Description

Specialized molecular diagnostics company with focus on hereditary cancer and pharmacogenomics. Comparable to Linear Care's specialty PGx and UroVysion FISH oncology testing.

TypeDirect peer
Description

Specialty lab offering drug-of-abuse and toxicology testing with employer and DTC channels. Comparable to Linear Care's pre-employment drug screening and toxicology services.

TypeEmerging player
Description

Molecular diagnostics company specializing in cell-free DNA and genetic testing. Comparable as a specialized molecular-diagnostics player, though Linear Care's menu is more infectious-disease and toxicology oriented.

TypeBroad incumbent
Description

International diagnostics operator with US specialty lab operations across molecular and anatomic pathology. Comparable as a broad incumbent across specialty molecular testing.

TypeBroad incumbent
Description

Second major US national reference lab with overlapping molecular diagnostics, infectious disease, and specialty testing menus. Comparable as a broad incumbent competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Linear Care Diagnostics

Clinical Diagnostic Laboratory Serviceslinearcaredx.com

Linear Care Diagnostics is an independent diagnostic laboratory in Addison, Texas offering infectious disease, toxicology, specialty oncology, and pharmacogenomic testing to individual patients, employers, and physician referrals via per-test cash-pay and insurance billing.

What Linear Care Diagnostics does

Linear Care Diagnostics is an independent diagnostic laboratory founded in 2022 and headquartered in Addison, Texas. The company operates a broad testing menu spanning infectious disease (COVID PCR and antigen, UTI, STI, RSV, wound, nail fungal), toxicology and drug screening, specialty oncology surveillance via UroVysion FISH for bladder cancer, and pharmacogenomic (PGx) testing. Underlying methodology combines standard molecular and analytical platforms — PCR, LC-MS/MS, fluorescence in situ hybridization, and PGx — with a proprietary software layer that the company claims delivers 99% accuracy and 24–48 hour result turnaround.

The business model is per-test fee-based, with cash-pay prices ranging from $35 (drug screen without nicotine) to $80 (drug screen with nicotine), and insurance billing for tests such as COVID PCR. Customers are reached through three primary channels: direct-to-consumer online self-scheduling, employer pre-employment and workplace drug screening, and physician referrals, the latter serving chronic pain management and bladder cancer surveillance workflows.

Linear Care Diagnostics reports a headcount in the 11–50 range and claims multiple physical testing locations, though only the Addison, TX site is confirmed. No funding rounds, acquisitions, partnerships, patents, certifications, or major customer accounts are disclosed in the available data. The company's competitive positioning rests on breadth of menu, fast turnaround, and DTC accessibility rather than on disclosed scientific differentiation or regulatory milestones.

Linear Care Diagnostics firmographics

Firmographics
Name
Linear Care Diagnostics
Legal name
Linear Care Diagnostics
Website
https://linearcaredx.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Linear Care Diagnostics is an independent diagnostic laboratory in Addison, Texas offering infectious disease, toxicology, specialty oncology, and pharmacogenomic testing to individual patients, employers, and physician referrals via per-test cash-pay and insurance billing.
Ownership category
akta.pro rank

Linear Care Diagnostics industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
akta.pro secondary industries
Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category) (HLAHAOAH), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

  • Molecular diagnostics
  • Clinical laboratory services
  • COVID PCR testing
  • Pharmacogenomics testing
  • Pre-employment drug screening

Where Linear Care Diagnostics is headquartered

Location

Headquarters

HQ city
Addison
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Linear Care Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Diagnostic Testing Services: One-time diagnostic testing services for patients including COVID PCR, antigen testing, UTI testing, STI testing, wound testing, nail fungal testing, RSV testing, pre-employment drug screening, UroVysion FISH, and PGx testing. Revenue is generated through per-test fees with option for insurance billing or cash pay.
  2. Insurance Billing: Accepts most insurance plans with doctor's orders. For uninsured patients, claims can be submitted through the CARES ACT.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPre-employment drug screen without nicotine - $35
Unit PricingPay-as-you-goPre-employment drug screen with nicotine - $80
OtherPay-as-you-goCOVID PCR and Antigen Testing - Insurance accepted

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Linear Care Diagnostics product offering

Product offering

Core offering

Linear Care Diagnostics is a clinical diagnostic laboratory that performs molecular and specialty testing — including COVID PCR, antigen, UTI, STI, wound, nail fungal, RSV, toxicology, UroVysion FISH bladder cancer, and pharmacogenomics (PGx) assays — using PCR, RT-PCR, LC-MS/MS, FISH, and proprietary software to deliver results in 24–48 hours (same-day at Addison, TX) with 99% accuracy. Tests can be ordered through physicians or booked directly by patients via the company website, with insurance or cash-pay billing options.

Product overview

Linear Care Diagnostics is a diagnostic laboratory offering a comprehensive suite of medical testing services. The company's portfolio includes COVID PCR Testing and Antigen Testing for respiratory infections, UTI Testing and STI Testing for infectious disease detection, Toxicology Testing and Pre-employment Drug Screening (with nicotine at $80 and without nicotine at $35) for medication monitoring, Wound Testing and Nail Fungal Testing using molecular PCR technology, RSV Testing for respiratory infections, UroVysion FISH Testing for bladder cancer detection, and PGx Testing for pharmacogenomics. The company emphasizes rapid turnaround times (24-48 hours for most tests) and high accuracy (99%+) through proprietary software and advanced analytical instruments.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 99% accuracy within 24-48 hours for most test results
  • +5 more outcomes

Companies that use Linear Care Diagnostics

Customer profile

Segments5 records

Ideal customer profiles3 records

Linear Care Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Linear Care Diagnostics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Linear Care Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • BioReference Laboratories: Full-service clinical lab with significant molecular diagnostics and specialty testing footprint. Comparable broad-incumbent competitor to Linear Care's specialty and routine test menu.
  • Quest Diagnostics: One of the two largest US clinical reference laboratories, offering the full range of molecular, toxicology, infectious-disease, and PGx testing. Competes with Linear Care across virtually every line item at national scale.
  • Sonic Healthcare USA: International diagnostics operator with US specialty lab operations across molecular and anatomic pathology. Comparable as a broad incumbent across specialty molecular testing.
  • Laboratory Corporation of America (Labcorp): Second major US national reference lab with overlapping molecular diagnostics, infectious disease, and specialty testing menus. Comparable as a broad incumbent competitor.

Direct peers

  • HealthTrackRx: Infectious-disease focused molecular diagnostics lab offering PCR-based testing with rapid turnaround. Directly comparable to Linear Care's infectious-disease menu (UTI, STI, wound, RSV).
  • Millennium Health: Specialty toxicology lab using LC-MS/MS for medication monitoring and substance use detection. Comparable to Linear Care's toxicology and chronic-pain monitoring offerings.
  • Aegis Sciences Corporation: Specialty clinical lab focused on toxicology, pharmacogenomics, and medication-monitoring testing. Directly comparable to Linear Care's PGx and toxicology services.
  • Confirm BioSciences: Specialty lab offering drug-of-abuse and toxicology testing with employer and DTC channels. Comparable to Linear Care's pre-employment drug screening and toxicology services.

Emerging players

  • Myriad Genetics: Specialized molecular diagnostics company with focus on hereditary cancer and pharmacogenomics. Comparable to Linear Care's specialty PGx and UroVysion FISH oncology testing.
  • Natera: Molecular diagnostics company specializing in cell-free DNA and genetic testing. Comparable as a specialized molecular-diagnostics player, though Linear Care's menu is more infectious-disease and toxicology oriented.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Linear Care Diagnostics social profiles

Digital presence

Linear Care Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Linear Care Diagnostics leadership team

Management profile

Number of profiles

Profiles2 records

Linear Care Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Linear Care Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Linear Care Diagnostics

What does Linear Care Diagnostics do?

Linear Care Diagnostics is a clinical diagnostic laboratory that performs molecular and specialty testing — including COVID PCR, antigen, UTI, STI, wound, nail fungal, RSV, toxicology, UroVysion FISH bladder cancer, and pharmacogenomics (PGx) assays — using PCR, RT-PCR, LC-MS/MS, FISH, and proprietary software to deliver results in 24–48 hours (same-day at Addison, TX) with 99% accuracy. Tests can be ordered through physicians or booked directly by patients via the company website, with insurance or cash-pay billing options.

Is Linear Care Diagnostics a public or private company?

Linear Care Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Linear Care Diagnostics founded?

Linear Care Diagnostics was founded in 2022. It employs 11 to 50 people.

Where is Linear Care Diagnostics based?

Linear Care Diagnostics is headquartered in Addison, United States, in the North America region.

How does Linear Care Diagnostics make money?

Two revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are insurance Billing.

Who are Linear Care Diagnostics's main competitors?

Broad incumbents on record are BioReference Laboratories, Quest Diagnostics, Sonic Healthcare USA and Laboratory Corporation of America (Labcorp). Direct peers are HealthTrackRx, Millennium Health, Aegis Sciences Corporation and Confirm BioSciences. Emerging players are Myriad Genetics and Natera.

Does Linear Care Diagnostics have an API?

No public API is recorded for Linear Care Diagnostics.

What industry is Linear Care Diagnostics in?

Linear Care Diagnostics's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales